Title:Image2Flow: A hybrid image and graph convolutional neural network for rapid patient-specific pulmonary artery segmentation and CFD flow field calculation from 3D cardiac MRI data

Abstract:Computational fluid dynamics (CFD) can be used for evaluation of hemodynamics. However, its routine use is limited by labor-intensive manual segmentation, CFD mesh creation, and time-consuming simulation. This study aims to train a deep learning model to both generate patient-specific volume-meshes of the pulmonary artery from 3D cardiac MRI data and directly estimate CFD flow fields.
This study used 135 3D cardiac MRIs from both a public and private dataset. The pulmonary arteries in the MRIs were manually segmented and converted into volume-meshes. CFD simulations were performed on ground truth meshes and interpolated onto point-point correspondent meshes to create the ground truth dataset. The dataset was split 85/10/15 for training, validation and testing. Image2Flow, a hybrid image and graph convolutional neural network, was trained to transform a pulmonary artery template to patient-specific anatomy and CFD values. Image2Flow was evaluated in terms of segmentation and accuracy of CFD predicted was assessed using node-wise comparisons. Centerline comparisons of Image2Flow and CFD simulations performed using machine learning segmentation were also performed.
Image2Flow achieved excellent segmentation accuracy with a median Dice score of 0.9 (IQR: 0.86-0.92). The median node-wise normalized absolute error for pressure and velocity magnitude was 11.98% (IQR: 9.44-17.90%) and 8.06% (IQR: 7.54-10.41), respectively. Centerline analysis showed no significant difference between the Image2Flow and conventional CFD simulated on machine learning-generated volume-meshes.
This proof-of-concept study has shown it is possible to simultaneously perform patient specific volume-mesh based segmentation and pressure and flow field estimation. Image2Flow completes segmentation and CFD in ~205ms, which ~7000 times faster than manual methods, making it more feasible in a clinical environment.